GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (BSP:A1SN34) » Definitions » Valuation Rank

Ascendis Pharma A/S (BSP:A1SN34) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Ascendis Pharma A/S Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ascendis Pharma A/S Valuation Rank Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (BSP:A1SN34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (BSP:A1SN34) » Definitions » Valuation Rank
Comparable Companies
ABCZF IMVT HALO PCVX APLS BBIO CERE MRTX KRTX ACAD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ASND:USA ASND:Mexico A71:Germany
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Website
http://www.ascendispharma.com
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.